OPKO Announces Fourth Quarter and Full Year 2013 Results

04-03-2014 Business Wire HealthComments (0)

BiotechnologyOPKO HealthPharmaceuticalUSA

OPKO Health (NYSE:OPK), a multi-national biopharmaceutical and diagnostics company, today reported operating and financial results for its 2013 fourth quarter and full year ended December 31, 2013. Financial Highlights For the fourth quarter of 2013, consolidated revenues increased about 30% to $20.7 million from $16.2 million in the prior year period. For the year ended December 31, 2013, consolidated revenues more than doubled to $96.5 million from $47.0 million

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top